mdl 72527 has been researched along with Adenocarcinoma, Basal Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amlong, CA; Basu, HS; Church, DR; Clower, CC; Lindstrom, MJ; Martin, CT; Mehraein-Ghomi, F; Thompson, TA; Wilding, G; Woster, PM | 1 |
| Agostinelli, E; Arancia, G; Belli, F; Condello, M; Seiler, N; Vedova, LD | 1 |
| Blanchard, Y; Chamaillard, L; Cipolla, B; Guillé, F; Havouis, R; Moulinoux, JP; Quemener, V | 1 |
| Cipolla, B; Guillé, F; Havouis, R; Lobel, B; Martin, C; Moulinoux, JP; Quemener, V; Seiler, N | 1 |
| Brasitus, TA; Chowdhury, LN; Davidson, NO; Dudeja, PK; Halline, AG; Jacoby, RF; Llor, X; Teng, BB | 1 |
5 other study(ies) available for mdl 72527 and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.
Topics: Acetyltransferases; Adenocarcinoma; Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Humans; Male; Mice; Mice, Transgenic; Oxidative Stress; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Prostatic Neoplasms; Putrescine; Reactive Oxygen Species; RNA, Small Interfering | 2009 |
Sensitization of human colon adenocarcinoma cells (LoVo) to reactive oxygen species by a lysosomotropic compound.
Topics: Adenocarcinoma; Aldehydes; Amine Oxidase (Copper-Containing); Animals; Antineoplastic Combined Chemotherapy Protocols; Cattle; Cell Survival; Colonic Neoplasms; Drug Resistance, Neoplasm; Humans; Hydrogen Peroxide; Lysosomes; Putrescine; Reactive Oxygen Species; Spermine; Tumor Cells, Cultured | 2006 |
In vivo, synergestic inhibition of MAT-LyLu rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Eflornithine; Lung Neoplasms; Male; Metronidazole; Neomycin; Oxidoreductases Acting on CH-NH Group Donors; Polyamines; Prostatic Neoplasms; Protein Synthesis Inhibitors; Putrescine; Rats; Rats, Inbred Strains; Survival Rate | 1996 |
The growth of MAT-LyLu rat prostatic adenocarcinoma can be prevented in vivo by polyamine deprivation.
Topics: Adenocarcinoma; Animals; Diet; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Eflornithine; Male; Neomycin; Neoplasm Transplantation; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polyamines; Prostatic Neoplasms; Putrescine; Rats; Rats, Inbred Strains | 1991 |
Effect of polyamine oxidase inhibition on the colonic malignant transformation process induced by 1,2-dimethylhydrazine.
Topics: 1,2-Dimethylhydrazine; Acetyltransferases; Adenocarcinoma; Animals; Base Sequence; Carcinogens; Colon; Colonic Neoplasms; Dimethylhydrazines; Genes, ras; Male; Molecular Sequence Data; Neoplasms, Experimental; Ornithine Decarboxylase; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polymerase Chain Reaction; Putrescine; Rats; Rats, Inbred Strains | 1990 |